Treace Medical Concepts Reports Third Quarter 2024 Financial Results
Revenue for the third quarter of 2024 was $45.1 million, representing an increase of 11% compared to $40.8 million in the third quarter of 2023. The increase was driven by product mix shift that resulted from increased adoption of newer technologies and increased sales of ancillary products used in bunion cases and an increase in active surgeons.
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...
PONTE VEDRA, Fla. (AP) — PONTE VEDRA, Fla. (AP) — Treace Medical Concepts Inc. (TMCI) on Tuesday reported a loss of $15.4 million in its third quarter. The Ponte Vedra, Florida-based company said it ...
Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) investors concerning the Company’s ...
News' Sharon Phillips' latest Cold Case investigation looks into the story of Gregory Treace who's been missing from Creek ...
The Law Offices of Frank R. Cruz announces an investigation of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI) on behalf of investors concerning the Company's possible ...
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Treace ...
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has received an average recommendation of “Hold” from the six research firms that are currently covering the company ...
Q3 2024 Revenue Growth Accelerates 15% to $17.2 Million. Commerce Revenue Grew 88% as Customers Choose Thinkific Commerce to Power Their Sales . Thinkific Plus and Self Serve Reve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback